Cases & Deals

  • Home
  • Practices
  • Burning Rock establishes global patent portfolio for NGS-related diagnostics and precision oncology

Share

Burning Rock establishes global patent portfolio for NGS-related diagnostics and precision oncology

February 2021

Client(s) Guangzhou Burning Rock Dx Co., Ltd.

Jones Day represents Burning Rock in the development and prosecution of global patent portfolios related to next generation sequencing (NGS) technology for diagnostic and of precision oncology.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.